Showing results (521-530 of 570) with videos related to

Sort By:
Pageof 57
Journal of the American Heart Association|September 13, 2021
LVS-HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World-Wide RegistryLinda S B Johnson, Jonas Oldgren, Tyler W Barrett, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|May 10, 2012
Ki-67 expression predicts radiotherapy failure in early glottic cancerAnthony C Nichols, Fiona Whelan, John Basmaji, et al.
Plos One|September 24, 2020
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer modelsNicole Pinto, Stephenie D Prokopec, Farhad Ghasemi, et al.
Injury|August 26, 2022
Assessment of safety and effectiveness of non-neurosurgical management for minimal traumatic brain injury (TBI)Jeffrey W Chen, Aaron Yengo-Kahn, Silky Chotai, et al.
Head & Neck|February 21, 2022
Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancerHugh A J Kim, Peter Y F Zeng, Alana Sorgini, et al.
JAMA Network Open|July 26, 2022
Effect of Smartphone App-Based Education on Clinician Prescribing Habits in a Learning Health Care System: A Randomized Cluster Crossover TrialMatthew D McEvoy, Mary Lynn Dear, Reagan Buie, et al.
Cell Reports. Medicine|May 16, 2026
Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancerPeter Y F Zeng, Jalna Meens, Amir Hossein Karimi, et al.
Head & Neck|December 7, 2023
HPV-negative head and neck cancers with adverse pathological features carry specific molecular changes that are associated with survivalHugh Andrew Jinwook Kim, Peter Y F Zeng, Matthew Cecchini, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2004
XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transportersKenneth C Cundy, Russell Branch, Tania Chernov-Rogan, et al.
Pageof 57